🟢 Femasys is trading 6.1% up today, extending a two-day rebound amid a broader biotech rally

Femasys is trading at $3.15 (6.1% up), extending a two-day recovery following a sharp slide last week.

• The upward move appears driven by broader bullish sentiment in U.S. equities and a general rally in biotech-related names.
• There are no new company-specific catalysts, earnings releases, or FDA decisions reported for the August 4 session.